Skip to main content

Beovu 6 mg/0.05 mL injection Images

Generic Name: brolucizumab

This medication has been identified as Beovu 6 mg/0.05 mL injection. It is supplied by Novartis Pharmaceuticals Corporation.

Beovu is used in the treatment of Diabetic Macular Edema; Macular Degeneration and belongs to the drug class anti-angiogenic ophthalmic agents. Beovu 6 mg/0.05 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Beovu 6 mg/0.05 mL injection medicine


Generic Name
6 mg/0.05 mL injection
Prescription only
Drug Class
Anti-angiogenic ophthalmic agents
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.